Publications by the researcher in collaboration with Jose Maria Moraleda Jimenez (2)

2016

  1. Circulating aberrant plasma cells allow risk stratification of patients with myeloma

    American Journal of Hematology

  2. Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing

    OncoImmunology, Vol. 5, Núm. 4